UCLA Journal of Radiation Oncology December First Edition - Flipbook - Page 37
UCLA RADIATION ONCOLOGY JOURNAL
AWARDS, PUBLICATIONS,
AND GRANTS
Recent wins from the UCLA Department of Radiation Oncology
Amar Kishan, M.D., was recently awarded
a $150,000 research grant from ViewRay,
Inc. to further his work on Stereotactic
Body Radiotherapy after Radical
Prostatectomy.
Carol Felix, Clinical Trials Network
Operations Manager, had her manuscript,
Clinical Research in the Time of COVID-19,
published in the International Journal of
Radiation Oncology, Biology, Physics.
Ann Raldow, M.D., recently partnered
with Intelligent Automation, INC. to win
a Phase II SBIR Grant from the NCI. The
study objective is to assess the impact
of patient symptom self-reporting using
the mPROS application during radiation
therapy on health-related quality of life
(HRQOL).
Amar Kishan, M.D. has been named
Associate Editor for Frontiers in Oncology
and to the Editorial Board of Cancers.
Stephanie Yoon, M.D., has become the
new Resident Membership Chair of
SWRO (Society for Women in Radiation
Oncology). SWRO has over three hundred
members nationally and internationally
who advocate for the advancement for
women in Radiation Oncology.
Kaley Woods, Ph.D., has received a Varian
grant on “Non-Coplanar Radiation Therapy
Using HyperArc in a Broad Population
of Head and Neck Cancer Patients”
supervised by Drs. Rob Chin, Ke Sheng
and Minsong Cao.
considerations for equipment selection,
clinical workflow, technology and
applications, as well as quality assurance
related to MR guided radiotherapy
(MRgRT).
Tania Kaprelian, M.D., had two recent
publications:
Comparison of Clinical Outcomes
Stratified by Target Delineation for
Patients Undergoing Stereotactic Body
Radiotherapy for Spinal Metastases (World
Neurosurgery)
Time-Driven Activity-Based Costing
Comparison of Stereotactic Radiosurgery
to Multiple Brain Lesions Using SingleIsocenter Versus Multiple-Isocenter
Technique (International Journal of
Radiation Oncology, Biology, Physics)
Amar Kishan, M.D., was the first author on
two recent publications:
Local Failure and Survival After Definitive
Radiotherapy for Aggressive Prostate
Cancer: An Individual Patient-Level
Meta-Analysis of Six Randomized Trials
(European Urology)
Transcriptomic Heterogeneity of Gleason
Group 5 Prostate Cancer (European
Urology)
Ann Raldow, M.D., was a first author on
a publication entitled, Cost Effectiveness
of DCISionRT for Guiding Treatment of
Ductal Carcinoma in Situ, published in
JNCI Cancer Spectrum.
Amar Kishan, M.D. Dr. Kishan's CRCC
Minsong Cao, Ph.D., was recently
appointed as Co-Chair of a recently formed 2020/2021 Application, Germline DNAbased Biomarkers of Toxicity Following
AAPM Task Group No. 325—MR-guided
Prostate Radiotherapy, was accepted and
Radiotherapy Systems: Considerations
selected for funding. It will be receiving a
for Clinical Implementation and Quality
Assurance. This task group is charged with $75,000 research grant.
providing recommendations including
37